Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 108,630 |
|
|||||
| News | - | ||||||
| Day High | 0.166 | Low High |
|||||
| Day Low | 0.1539 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Sonoma Pharmaceuticals Inc | SNOA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0089 | -5.55% | 0.1515 | 17:43:57 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.165 | 0.1539 | 0.166 | 0.159 | 0.1604 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 381 | 108,630 | US$ 0.1626936 | US$ 17,673 | - | 0.1159 - 1.52 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:07:01 | 51 | US$ 0.1566 | USD |
Sonoma Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.5M | 15.61M | - | 13.27M | -5.15M | -0.33 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Sonoma Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/08/2024 | 15:29 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/08/2024 | 15:27 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 2/08/2024 | 15:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 1/10/2024 | 06:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/09/2024 | 15:47 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/29/2023 | 16:26 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/29/2023 | 16:25 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/29/2023 | 16:25 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/29/2023 | 16:24 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/29/2023 | 16:23 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/15/2023 | 16:30 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 11/20/2023 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SNOA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.148 | 0.1699 | 0.148 | 0.1568469 | 127,525 | 0.0035 | 2.36% |
| 1 Month | 0.153 | 0.185 | 0.138 | 0.1605282 | 372,924 | -0.0015 | -0.98% |
| 3 Months | 0.17 | 0.1919 | 0.1311 | 0.1579075 | 532,842 | -0.0185 | -10.88% |
| 6 Months | 0.185 | 0.3108 | 0.1159 | 0.1869203 | 1,537,684 | -0.0335 | -18.11% |
| 1 Year | 0.991 | 1.52 | 0.1159 | 0.3625745 | 906,942 | -0.8395 | -84.71% |
| 3 Years | 8.00 | 13.36 | 0.1159 | 3.32 | 926,290 | -7.85 | -98.11% |
| 5 Years | 0.84 | 19.54 | 0.1159 | 4.37 | 681,069 | -0.6885 | -81.96% |
Sonoma Pharmaceuticals Description
| Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes and others. The company derives revenue from the sale of products in the United States, Latin America, Europe and other countries. |
